Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer

According to clinical and pathological factors the prognosis of a patient with non-muscle invasive bladder tumors can be assessed. The prognosis is determined by the likelihood of recurrence(30-70%) and/or progression to muscle invasive bladder cancer(1-15%).Trans urethral resection of bladder tumor...

Descripción completa

Detalles Bibliográficos
Autor principal: van der Meijden, A.P.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2006
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917213/
https://www.ncbi.nlm.nih.gov/pubmed/17619738
http://dx.doi.org/10.1100/tsw.2006.403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917213/
https://www.ncbi.nlm.nih.gov/pubmed/17619738
http://dx.doi.org/10.1100/tsw.2006.403

Ejemplares similares